Lanthanum Carbonate

CHEMBL2096647 Phase 4 Aprobado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

457.8 g/mol

LogP

—

Phase

4

A phosphate binder for dialysis patients with high phosphate levels.

Peso molecular

457,8400 g/mol

TPSA

190,00 Å²

Áreas terapéuticas

Chronic Kidney Disease Cardiovascular Disease

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

C(=O)([O-])[O-].C(=O)([O-])[O-].C(=O)([O-])[O-].[La+3].[La+3]

InChI

InChI=1S/3CH2O3.2La/c3*2-1(3)4;;/h3*(H2,2,3,4);;/q;;;2*+3/p-6

Molecular Formula

C3La2O9

HBD / HBA

- / 9

Enlaces Rotables

0

Átomos Pesados

14

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

A phosphate binder for dialysis patients with high phosphate levels.

Yes, Lanthanum Carbonate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2096647. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 168924. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

¿Busca información accesible para el paciente?

Lanthanum Carbonate en PillFYI

Estructura

Datos Rápidos

Fórmula: C3La2O9
Sinónimos: 2

Enlaces externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.